{"id":"https://openalex.org/W2964089404","doi":"https://doi.org/10.1080/13543784.2019.1646726","title":"A Multidisciplinary Evaluation of Barriers to Enrolling Cancer Patients into Early Phase Clinical Trials: Challenges and Patient-centric Recommendations","display_name":"A Multidisciplinary Evaluation of Barriers to Enrolling Cancer Patients into Early Phase Clinical Trials: Challenges and Patient-centric Recommendations","publication_year":2019,"publication_date":"2019-07-22","ids":{"openalex":"https://openalex.org/W2964089404","doi":"https://doi.org/10.1080/13543784.2019.1646726","mag":"2964089404","pmid":"https://pubmed.ncbi.nlm.nih.gov/31327293"},"language":"en","primary_location":{"id":"doi:10.1080/13543784.2019.1646726","doi":"https://doi.org/10.1080/13543784.2019.1646726","is_oa":false,"landing_page_url":"https://doi.org/10.1080/13543784.2019.1646726","pdf_url":null,"source":{"id":"https://openalex.org/S131064935","display_name":"Expert Opinion on Investigational Drugs","issn_l":"1354-3784","issn":["1354-3784","1744-7658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Investigational Drugs","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059022515","display_name":"Hani M. Babiker","orcid":"https://orcid.org/0000-0002-9368-6296","observed_orcids":["https://orcid.org/0000-0002-9368-6296"]},"institutions":[{"id":"https://openalex.org/I4390039223","display_name":"University of Arizona Cancer Center","ror":"https://ror.org/04tvx8690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039223"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Hani M Babiker","raw_affiliation_strings":["Department of Medicine, Division of Hematology-Oncology, University of Arizona Cancer Center, Early Phase Clinical Trials Program, Tucson, AZ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Hematology-Oncology, University of Arizona Cancer Center, Early Phase Clinical Trials Program, Tucson, AZ, USA","institution_ids":["https://openalex.org/I4390039223"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003891938","display_name":"Lisa E. Davis","orcid":"https://orcid.org/0000-0003-1384-1610","observed_orcids":["https://orcid.org/0000-0003-1384-1610"]},"institutions":[{"id":"https://openalex.org/I4390039223","display_name":"University of Arizona Cancer Center","ror":"https://ror.org/04tvx8690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039223"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lisa Davis","raw_affiliation_strings":["Department of Medicine, Division of Hematology-Oncology, University of Arizona Cancer Center, Early Phase Clinical Trials Program, Tucson, AZ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Hematology-Oncology, University of Arizona Cancer Center, Early Phase Clinical Trials Program, Tucson, AZ, USA","institution_ids":["https://openalex.org/I4390039223"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004869107","display_name":"Kristian Larson","orcid":"https://orcid.org/0000-0003-3071-6387","observed_orcids":["https://orcid.org/0000-0003-3071-6387"]},"institutions":[{"id":"https://openalex.org/I4390039223","display_name":"University of Arizona Cancer Center","ror":"https://ror.org/04tvx8690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039223"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kristian Larson","raw_affiliation_strings":["Department of Medicine, Division of Hematology-Oncology, University of Arizona Cancer Center, Early Phase Clinical Trials Program, Tucson, AZ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Hematology-Oncology, University of Arizona Cancer Center, Early Phase Clinical Trials Program, Tucson, AZ, USA","institution_ids":["https://openalex.org/I4390039223"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006684635","display_name":"Crystal Placencia","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4390039223","display_name":"University of Arizona Cancer Center","ror":"https://ror.org/04tvx8690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039223"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Crystal Placencia","raw_affiliation_strings":["Department of Medicine, Division of Hematology-Oncology, University of Arizona Cancer Center, Early Phase Clinical Trials Program, Tucson, AZ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Hematology-Oncology, University of Arizona Cancer Center, Early Phase Clinical Trials Program, Tucson, AZ, USA","institution_ids":["https://openalex.org/I4390039223"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038479621","display_name":"Connor Swensen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4390039223","display_name":"University of Arizona Cancer Center","ror":"https://ror.org/04tvx8690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039223"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Connor Swensen","raw_affiliation_strings":["Department of Medicine, Division of Hematology-Oncology, University of Arizona Cancer Center, Early Phase Clinical Trials Program, Tucson, AZ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Hematology-Oncology, University of Arizona Cancer Center, Early Phase Clinical Trials Program, Tucson, AZ, USA","institution_ids":["https://openalex.org/I4390039223"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020174810","display_name":"Pavan Tenneti","orcid":"https://orcid.org/0000-0001-7446-0470","observed_orcids":["https://orcid.org/0000-0001-7446-0470"]},"institutions":[{"id":"https://openalex.org/I4210103827","display_name":"Banner - University Medical Center Phoenix","ror":"https://ror.org/01cjjjf51","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2802412784","https://openalex.org/I4210103827"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pavan Tenneti","raw_affiliation_strings":["Department of Medicine, Banner University Medical Center Phoenix, Phoenix, AZ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Banner University Medical Center Phoenix, Phoenix, AZ, USA","institution_ids":["https://openalex.org/I4210103827"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Melissa Lim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4390039223","display_name":"University of Arizona Cancer Center","ror":"https://ror.org/04tvx8690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039223"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Melissa Lim","raw_affiliation_strings":["Department of Medicine, Division of Hematology-Oncology, University of Arizona Cancer Center, Early Phase Clinical Trials Program, Tucson, AZ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Hematology-Oncology, University of Arizona Cancer Center, Early Phase Clinical Trials Program, Tucson, AZ, USA","institution_ids":["https://openalex.org/I4390039223"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038869307","display_name":"Ruth Ca\u00f1amar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4390039223","display_name":"University of Arizona Cancer Center","ror":"https://ror.org/04tvx8690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039223"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ruth Ca\u00f1amar","raw_affiliation_strings":["Department of Medicine, Division of Hematology-Oncology, University of Arizona Cancer Center, Early Phase Clinical Trials Program, Tucson, AZ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Hematology-Oncology, University of Arizona Cancer Center, Early Phase Clinical Trials Program, Tucson, AZ, USA","institution_ids":["https://openalex.org/I4390039223"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Jacqueline Curtis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4390039223","display_name":"University of Arizona Cancer Center","ror":"https://ror.org/04tvx8690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039223"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jacqueline Curtis","raw_affiliation_strings":["Department of Medicine, Division of Hematology-Oncology, University of Arizona Cancer Center, Early Phase Clinical Trials Program, Tucson, AZ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Hematology-Oncology, University of Arizona Cancer Center, Early Phase Clinical Trials Program, Tucson, AZ, USA","institution_ids":["https://openalex.org/I4390039223"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023519041","display_name":"Erica Castillo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4390039223","display_name":"University of Arizona Cancer Center","ror":"https://ror.org/04tvx8690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039223"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Erica Castillo","raw_affiliation_strings":["Department of Medicine, Division of Hematology-Oncology, University of Arizona Cancer Center, Early Phase Clinical Trials Program, Tucson, AZ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Hematology-Oncology, University of Arizona Cancer Center, Early Phase Clinical Trials Program, Tucson, AZ, USA","institution_ids":["https://openalex.org/I4390039223"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087107452","display_name":"James J. Mancuso","orcid":"https://orcid.org/0000-0001-5776-8617","observed_orcids":["https://orcid.org/0000-0001-5776-8617"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James Mancuso","raw_affiliation_strings":["Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044062732","display_name":"Diane Rensvold","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4390039223","display_name":"University of Arizona Cancer Center","ror":"https://ror.org/04tvx8690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039223"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Diane Rensvold","raw_affiliation_strings":["Department of Medicine, Division of Hematology-Oncology, University of Arizona Cancer Center, Early Phase Clinical Trials Program, Tucson, AZ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Hematology-Oncology, University of Arizona Cancer Center, Early Phase Clinical Trials Program, Tucson, AZ, USA","institution_ids":["https://openalex.org/I4390039223"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Sarah Martinez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4390039223","display_name":"University of Arizona Cancer Center","ror":"https://ror.org/04tvx8690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039223"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sarah Martinez","raw_affiliation_strings":["Department of Medicine, Division of Hematology-Oncology, University of Arizona Cancer Center, Early Phase Clinical Trials Program, Tucson, AZ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Hematology-Oncology, University of Arizona Cancer Center, Early Phase Clinical Trials Program, Tucson, AZ, USA","institution_ids":["https://openalex.org/I4390039223"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039970518","display_name":"Lora Macias","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4390039223","display_name":"University of Arizona Cancer Center","ror":"https://ror.org/04tvx8690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039223"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lora Macias","raw_affiliation_strings":["Department of Medicine, Division of Hematology-Oncology, University of Arizona Cancer Center, Early Phase Clinical Trials Program, Tucson, AZ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Hematology-Oncology, University of Arizona Cancer Center, Early Phase Clinical Trials Program, Tucson, AZ, USA","institution_ids":["https://openalex.org/I4390039223"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018235125","display_name":"Alejandro Recio\u2010Boiles","orcid":"https://orcid.org/0000-0002-5423-3112","observed_orcids":["https://orcid.org/0000-0002-5423-3112"]},"institutions":[{"id":"https://openalex.org/I4390039223","display_name":"University of Arizona Cancer Center","ror":"https://ror.org/04tvx8690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039223"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alejandro Recio-Boiles","raw_affiliation_strings":["Department of Medicine, Division of Hematology-Oncology, University of Arizona Cancer Center, Early Phase Clinical Trials Program, Tucson, AZ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Hematology-Oncology, University of Arizona Cancer Center, Early Phase Clinical Trials Program, Tucson, AZ, USA","institution_ids":["https://openalex.org/I4390039223"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110574746","display_name":"Sreenivasa Rao Chandana","orcid":"https://orcid.org/0000-0001-5390-9937","observed_orcids":["https://orcid.org/0000-0001-5390-9937"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sreenivasa R Chandana","raw_affiliation_strings":["Department of Gastrointestinal Medical Oncology, Cancer and Hematology Centers of Western Michigan, Phase I Program, START Midwest, Grand Rapids, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Gastrointestinal Medical Oncology, Cancer and Hematology Centers of Western Michigan, Phase I Program, START Midwest, Grand Rapids, MI, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101638085","display_name":"Daruka Mahadevan","orcid":"https://orcid.org/0000-0002-7129-5593","observed_orcids":["https://orcid.org/0000-0002-7129-5593"]},"institutions":[{"id":"https://openalex.org/I4390039223","display_name":"University of Arizona Cancer Center","ror":"https://ror.org/04tvx8690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039223"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daruka Mahadevan","raw_affiliation_strings":["Department of Medicine, Division of Hematology-Oncology, University of Arizona Cancer Center, Early Phase Clinical Trials Program, Tucson, AZ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Hematology-Oncology, University of Arizona Cancer Center, Early Phase Clinical Trials Program, Tucson, AZ, USA","institution_ids":["https://openalex.org/I4390039223"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5059022515"],"corresponding_institution_ids":["https://openalex.org/I4390039223"],"apc_list":null,"apc_paid":null,"fwci":0.0808,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.18685043,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":95},"biblio":{"volume":"28","issue":"8","first_page":"675","last_page":"686"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10582","display_name":"Ethics in Clinical Research","score":0.9613999724388123,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10582","display_name":"Ethics in Clinical Research","score":0.9613999724388123,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.024800000712275505,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12168","display_name":"Health and Medical Research Impacts","score":0.004800000227987766,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cancer-clinical-trials","display_name":"cancer clinical trials","score":0.7710000276565552},{"id":"https://openalex.org/keywords/trial-enrollment-barriers","display_name":"trial enrollment barriers","score":0.8339999914169312},{"id":"https://openalex.org/keywords/advanced-cancer-patients","display_name":"advanced cancer patients","score":0.8700000047683716},{"id":"https://openalex.org/keywords/investigator-role","display_name":"investigator role","score":0.46299999952316284},{"id":"https://openalex.org/keywords/regulatory-challenges","display_name":"regulatory challenges","score":0.8610000014305115},{"id":"https://openalex.org/keywords/research-nurses","display_name":"research nurses","score":0.7929999828338623},{"id":"https://openalex.org/keywords/clinical-research-coordinators","display_name":"clinical research coordinators","score":0.996999979019165},{"id":"https://openalex.org/keywords/data-management","display_name":"data management","score":0.8999999761581421},{"id":"https://openalex.org/keywords/drug-approval","display_name":"drug approval","score":0.46700000762939453},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.9269999861717224}],"concepts":[{"id":"https://openalex.org/C22467394","wikidata":"https://www.wikidata.org/wiki/Q849359","display_name":"Multidisciplinary approach","level":2,"score":0.6301360726356506},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6031402349472046},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5936771631240845},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4786885380744934},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.4735229015350342},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.23768875002861023},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.10554119944572449},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000076722","descriptor_name":"Drug Development","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D003299","descriptor_name":"Cooperative Behavior","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D014408","descriptor_name":"Biomarkers, Tumor","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014486","descriptor_name":"United States Food and Drug Administration","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017277","descriptor_name":"Drug Approval","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018579","descriptor_name":"Patient Selection","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1080/13543784.2019.1646726","doi":"https://doi.org/10.1080/13543784.2019.1646726","is_oa":false,"landing_page_url":"https://doi.org/10.1080/13543784.2019.1646726","pdf_url":null,"source":{"id":"https://openalex.org/S131064935","display_name":"Expert Opinion on Investigational Drugs","issn_l":"1354-3784","issn":["1354-3784","1744-7658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Investigational Drugs","raw_type":"journal-article"},{"id":"pmid:31327293","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31327293","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on investigational drugs","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.979200005531311,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":32,"referenced_works":["https://openalex.org/W1495287984","https://openalex.org/W1789241489","https://openalex.org/W1903756589","https://openalex.org/W1975314229","https://openalex.org/W1995279104","https://openalex.org/W2014205736","https://openalex.org/W2023137785","https://openalex.org/W2043990618","https://openalex.org/W2087545659","https://openalex.org/W2108890677","https://openalex.org/W2117963308","https://openalex.org/W2129684544","https://openalex.org/W2133779471","https://openalex.org/W2149626936","https://openalex.org/W2169644362","https://openalex.org/W2207200267","https://openalex.org/W2246743638","https://openalex.org/W2274227841","https://openalex.org/W2298846890","https://openalex.org/W2417768567","https://openalex.org/W2468350542","https://openalex.org/W2586220533","https://openalex.org/W2593056712","https://openalex.org/W2599632082","https://openalex.org/W2605247212","https://openalex.org/W2750240778","https://openalex.org/W2774209421","https://openalex.org/W2783137027","https://openalex.org/W2802181510","https://openalex.org/W2804880019","https://openalex.org/W2981117660","https://openalex.org/W4251299251"],"related_works":["https://openalex.org/W2567461836","https://openalex.org/W4212901367","https://openalex.org/W2111850393","https://openalex.org/W4245796804","https://openalex.org/W3092864137","https://openalex.org/W2947583711","https://openalex.org/W2137450416","https://openalex.org/W2335314299","https://openalex.org/W4389239800","https://openalex.org/W3138768159"],"abstract_inverted_index":{"Introduction:":[0],"Early":[1],"phase":[2,47,89,174],"clinical":[3,8,118,175],"trials":[4,44,176],"are":[5,29,105,128],"the":[6,32,60,77,87,92,108,111,169],"first":[7],"research":[9,116,119],"step":[10],"to":[11,16,39,70,76,101],"bringing":[12],"new":[13,22,54,64,74],"cancer":[14,99],"therapeutics":[15],"patients.":[17],"At":[18],"this":[19],"stage,":[20],"a":[21,130,146],"drug\u2019s":[23],"safety,":[24],"dosing,":[25],"and":[26,41,91,123,157,161,178],"scheduling":[27],"profiles":[28],"established":[30],"as":[31],"main":[33],"endpoints.":[34],"However,":[35],"excellent":[36],"responses":[37],"due":[38],"biomarker-guided":[40],"immune":[42],"checkpoint":[43],"in":[45,50,96,133],"early":[46,88,173],"have":[48],"resulted":[49],"direct":[51],"approvals":[52],"of":[53,59,63,84,86,110,139,168,181],"anti-cancer":[55],"drugs.":[56,141],"Despite":[57],"doubling":[58],"success":[61],"rate":[62],"drug":[65,134],"approvals,":[66],"many":[67],"barriers":[68],"exist":[69],"expeditiously":[71],"bring":[72],"active":[73],"drugs":[75],"clinic.Areas":[78],"covered:":[79],"This":[80,142],"review":[81],"covers":[82],"roles":[83],"members":[85],"program":[90],"challenges":[93,170],"they":[94],"face":[95],"enrolling":[97],"advanced":[98],"patients":[100],"trials.":[102],"Practical":[103],"solutions":[104],"provided":[106],"from":[107],"perspective":[109],"investigators,":[112,150],"regulatory,":[113],"investigational":[114],"pharmacy,":[115],"nurses,":[117],"coordinators,":[120],"budgets,":[121],"contracts,":[122],"data":[124],"management.Expert":[125],"opinion:":[126],"We":[127],"witnessing":[129],"burgeoning":[131],"era":[132],"development":[135],"with":[136],"rapid":[137],"approval":[138],"efficacious":[140],"is":[143],"achieved":[144],"by":[145,172],"strong":[147],"collaboration":[148],"between":[149],"academic":[151],"institutions,":[152],"pharmaceutical":[153],"sponsors,":[154],"scientists,":[155],"Food":[156],"Drug":[158],"Administration":[159],"(FDA),":[160],"community":[162],"practices.":[163],"Herein,":[164],"we":[165],"discuss":[166,179],"some":[167],"faced":[171],"programs":[177],"methods":[180],"improvement.":[182]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2020,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2019-07-30T00:00:00"}